COVID Intel - by William Makis (McGill Medicine)

COVID Intel - by William Makis (McGill Medicine)

HIGH DOSE VITAMIN C and CANCER - What does latest research show? 3 key papers reviewed

William Makis's avatar
William Makis
Nov 05, 2023
∙ Paid
Fig. 6

Image Source: 2021 Oct (Bottger et al) - High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer

Papers Reviewed:

  • 2023 June (Dianfa Fan et al) - Cell signaling pathways based on vitamin C and their application in cancer therapy

  • 2021 Oct (Bottger et al) - High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer

  • 2021 Feb (Zasowska-Nowak et al) - High-Dose Vitamin C in Advanced-Stage Cancer Patients

Keep reading with a 7-day free trial

Subscribe to COVID Intel - by William Makis (McGill Medicine) to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 William Makis
Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture